This site is intended for healthcare professionals

Novinky z letošního nejvýznamnějšího setkání onkologů 2017

A phase III trial of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade for HER2+ breast cancer: The TRAIN-2 study (BOOG 2012-03)

Mette S. Van Ramshorst, Erik van Werkhoven, Ingrid A. Mandjes, Inge Kemper, Vincent O. Dezentjé, Irma M. Oving, Aafke H. Honkoop, Lidwine W Tick, Agnes W Van de Wouw, Caroline M Mandigers, Jelle Wesseling, Marie-Jeanne Vrancken Peeters, Sabine C. Linn, Gabe S. Sonke

Dutch Breast Cancer Research Group (BOOG)
Netherlands Cancer Institute, Amsterdam, Netherlands
Reinier de Graaf Groep, Delft, Netherlands
Ziekenhuisgroep Twente (ZGT), Almelo, Netherlands
Isala Clinics, Zwolle, NetherlandsMáxima Medical Center, Eindhoven, Netherlands
Viecuri Medical Centre, Venlo, Netherlands
Canisius Wilhelmina Hospital, Nijmegen, Netherlands
Department of Medical Oncology- Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, NetherlandsView Less

Meeting: 2017 ASCO Annual Meeting   Track: Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy   Abstract number: 507   Citation: J Clin Oncol 35, 2017 (suppl; abstr 507)   Author(s): Mette S. Van Ramshorst, Erik van Werkhoven, Ingrid A. Mandjes, Inge Kemper, Vincent O. Dezentjé, Irma M. Oving, Aafke H. Honkoop, Lidwine W Tick, Agnes W Van de Wouw,...

Zpět

Myelodysplastic Syndrome News č. 1/2021 Czech edition

28 | 04 | 2021

Chystáme nové vydání časopisu Myelodysplastic Syndrome News.

Žijeme s roztroušenou sklerózou č. 1/2021

23 | 04 | 2021

Chystáme letošní první vydání časopisu Žijeme s roztroušenou sklerózou.

PragueONCO News č. 1/2021

19 | 04 | 2021

Již brzy vyjdou noviny PragueONCO News.




Partneři projektu